LSU Health New Orleans announced the publication of a groundbreaking study led by Giulia Monticone, PhD, in the prestigious journal EMBO Reports.
The study’s publication is live at https://doi.org/10.1038/s44319-024-00189-4.
This study unveils that the antiviral effects of the COVID-19 drug remdesivir are primarily due to a novel immunological mechanism rather than direct antiviral activity.

Terrebonne General Health System recently welcomed Rory A. Eschete, II, MD, and Brendon J. Gros, MD.